FMXIN002 in Patients at Risk of Anaphylaxis
Trial details
- Registry ID
- NCT07045701
- Phase
- Phase 2, Phase 3
Drug identity has not yet been verified against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| FMXIN002 in Patients at Risk of AnaphylaxisNCT07045701 | Nasus Pharma | Phase 2, Phase 3 | Enrolling by invitation | 2026-06-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |